• Users Online: 61
  • Print this page
  • Email this page

Table of Contents
Year : 2020  |  Volume : 9  |  Issue : 2  |  Page : 128-129

Containment of coronavirus disease-2019 outbreak: Lessons learnt from China

1 Member of the Medical Education Unit and Institute Research Council, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Ammapettai, Nellikuppam, Chengalpet District, Tamil Nadu, India
2 Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Ammapettai, Nellikuppam, Chengalpet District, Tamil Nadu, India

Date of Submission10-Mar-2020
Date of Decision05-Apr-2020
Date of Acceptance16-Apr-2020
Date of Web Publication4-Aug-2020

Correspondence Address:
Saurabh RamBihariLal Shrivastava
Professor, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth (SBV) – Deemed to be University, Tiruporur - Guduvancherry Main Road, Ammapettai, Nellikuppam, Chengalpaet District - 603108, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JCSR.JCSR_18_20

Rights and Permissions

How to cite this article:
Shrivastava SR, Shrivastava PS. Containment of coronavirus disease-2019 outbreak: Lessons learnt from China. J Clin Sci Res 2020;9:128-9

How to cite this URL:
Shrivastava SR, Shrivastava PS. Containment of coronavirus disease-2019 outbreak: Lessons learnt from China. J Clin Sci Res [serial online] 2020 [cited 2020 Oct 26];9:128-9. Available from: https://www.jcsr.co.in/text.asp?2020/9/2/128/291369

The novel coronavirus disease 2019 (COVID 19) outbreak has emerged as the biggest public health challenge in the new decade; it has not only raised a global alarm but also made us to introspect ourselves about our level of preparedness to deal with the public health emergencies.[1],[2] The available estimates suggest that overall 1,051,635 cases of the disease have been reported, of which 92.1% are reported outside China, which is an encouraging sign considering that for the initial close to 2 months, China was alone the epicentre of the disease.[1] The pace of the disease international spread has been very quick, and since the start of the outbreak in China, 208 more nations and territories have reported cases and it is increasing with each day.[1],[3] Further, 56,985 deaths have also been attributed to the novel viral infections and it requires global prioritisation for ensuring its effective containment.[1]

However, the recent trends of the disease suggest that China has become successful to significantly reduce the incidence of the disease, owing to their aggressive, dedicated and need based approach, despite being very much deprived of the facts (e.g., virological, epidemiological and clinical attributes) about the disease.[4] This is evident from the fact that within a single day, only 73 cases were reported, while the rest of the world accounted for 79,259 cases in the same time frame of 24 h.[1] The need of the hour is to accept that the entire global population is prone to acquire this novel infection and thus be proactive, yet flexible enough to alter the containment strategies, with the evolution of the viral infection.[2],[3]

China's success to contain the infection was mainly because of the thorough risk assessment of the different provinces, development of prompt response plan, the adoption of non pharmacological interventions and customising the public health response.[2 4] Even though all this looks quite impressive and appealing, the reality is that even after 2 months since the outbreak was first detected, the preparedness level of the global community has not reached expected standards to effectively contain the infection within their settings.[4],[5] We have still been finding it hard to ensure that facilities for active surveillance, rapid detection, case isolation, contact tracing, risk communication and involvement of the community in various public health activities are in place.[3 5] Amidst the lack of uncertainty like when a potent vaccine or drug will be available, it is the need of the hour that the national policy makers should take strong steps to prevent the risk of an uncontrolled and community level transmission.[2],[4],[5]

From the global perspective, it is important to acknowledge that, at present, majority of the high and middle income nations are reporting cases, and thus, it is their responsibility to ensure that the infection does not spread further to low income nations from them, as in that case the weakness of the healthcare delivery system will be exposed and we will lose thousands of lives to the novel infection.[4] It is extremely vital to utilise the available time efficiently and improve our abilities and capacities to contain the infection by interrupting the chain of transmission.[3] Further, we have to invest extensively in epidemiological studies and research and development activities not only in China but also across the world, as the findings or products will aid us significantly in improving our response to the outbreak.[2 4]

In conclusion, the world is encountering, at present, one of the major public health emergencies and it is high time to be proactive, aggressive and replicate the strategies implemented in China across all the other affected nations to avoid the risk of community transmission and loss of human lives.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report – 75. World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200404-sitrep-75-covid-19.pdf?sfvrsn=99251b2b_2. [Last accessed on 2020 Apr 05].  Back to cited text no. 1
Lee A. Wuhan novel coronavirus (COVID-19): Why global control is challenging? Public Health 2020;179:A1-2.  Back to cited text no. 2
Cohen J, Kupferschmidt K. Strategies shift as coronavirus pandemic looms. Science 2020;367:962-3.  Back to cited text no. 3
World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva: World Health Organization; 2020.p. 18-22.  Back to cited text no. 4
World Health Organization. 2019 Novel Coronavirus (2019nCoV): Strategic Preparedness and Response Plan. Geneva: World Health Organization; 2020.p. 1-20.  Back to cited text no. 5


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal